Evergrande's ongoing debt saga, US FED's September meeting, Johnson and Johnson's vaccine efficacy, Biolidics' ClearEpi NAB test product, Singapore's bonds issue and APAC markets in early trade

We cover the latest development in the China's Evergrande default story, what investors will to look out for when Jermone Powell speaks at the FOMC meeting today and what catalyst listed Biolodics test product will be able to do.

Michelle Martin and Ryan Huang go beyond the news headlines in this edition of Market View. 

See omnystudio.com/listener for privacy information.